Cargando…

Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model

BACKGROUND: The gut microbiota has recently attracted attention as a pathogenic factor in Alzheimer’s disease (AD). Microfold (M) cells, which play a crucial role in the gut immune response against external antigens, are also exploited for the entry of pathogenic bacteria and proteins into the body....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Namkwon, Ju, In Gyoung, Jeon, Seung Ho, Lee, Yeongae, Jung, Min-Ji, Gee, Min Sung, Cho, Jae Seok, Inn, Kyung-Soo, Garrett-Sinha, Lee Ann, Oh, Myung Sook, Lee, Jong Kil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680211/
https://www.ncbi.nlm.nih.gov/pubmed/38012646
http://dx.doi.org/10.1186/s12974-023-02966-9
_version_ 1785150677420343296
author Kim, Namkwon
Ju, In Gyoung
Jeon, Seung Ho
Lee, Yeongae
Jung, Min-Ji
Gee, Min Sung
Cho, Jae Seok
Inn, Kyung-Soo
Garrett-Sinha, Lee Ann
Oh, Myung Sook
Lee, Jong Kil
author_facet Kim, Namkwon
Ju, In Gyoung
Jeon, Seung Ho
Lee, Yeongae
Jung, Min-Ji
Gee, Min Sung
Cho, Jae Seok
Inn, Kyung-Soo
Garrett-Sinha, Lee Ann
Oh, Myung Sook
Lee, Jong Kil
author_sort Kim, Namkwon
collection PubMed
description BACKGROUND: The gut microbiota has recently attracted attention as a pathogenic factor in Alzheimer’s disease (AD). Microfold (M) cells, which play a crucial role in the gut immune response against external antigens, are also exploited for the entry of pathogenic bacteria and proteins into the body. However, whether changes in M cells can affect the gut environments and consequently change brain pathologies in AD remains unknown. METHODS: Five familial AD (5xFAD) and 5xFAD-derived fecal microbiota transplanted (5xFAD-FMT) naïve mice were used to investigate the changes of M cells in the AD environment. Next, to establish the effect of M cell depletion on AD environments, 5xFAD mice and Spib knockout mice were bred, and behavioral and histological analyses were performed when M cell-depleted 5xFAD mice were six or nine months of age. RESULTS: In this study, we found that M cell numbers were increased in the colons of 5xFAD and 5xFAD-FMT mice compared to those of wild-type (WT) and WT-FMT mice. Moreover, the level of total bacteria infiltrating the colons increased in the AD-mimicked mice. The levels of M cell-related genes and that of infiltrating bacteria showed a significant correlation. The genetic inhibition of M cells (Spib knockout) in 5xFAD mice changed the composition of the gut microbiota, along with decreasing proinflammatory cytokine levels in the colons. M cell depletion ameliorated AD symptoms including amyloid-β accumulation, microglial dysfunction, neuroinflammation, and memory impairment. Similarly, 5xFAD-FMT did not induce AD-like pathologies, such as memory impairment and excessive neuroinflammation in Spib(−/−) mice. CONCLUSION: Therefore, our findings provide evidence that the inhibiting M cells can prevent AD progression, with therapeutic implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02966-9.
format Online
Article
Text
id pubmed-10680211
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106802112023-11-27 Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model Kim, Namkwon Ju, In Gyoung Jeon, Seung Ho Lee, Yeongae Jung, Min-Ji Gee, Min Sung Cho, Jae Seok Inn, Kyung-Soo Garrett-Sinha, Lee Ann Oh, Myung Sook Lee, Jong Kil J Neuroinflammation Research BACKGROUND: The gut microbiota has recently attracted attention as a pathogenic factor in Alzheimer’s disease (AD). Microfold (M) cells, which play a crucial role in the gut immune response against external antigens, are also exploited for the entry of pathogenic bacteria and proteins into the body. However, whether changes in M cells can affect the gut environments and consequently change brain pathologies in AD remains unknown. METHODS: Five familial AD (5xFAD) and 5xFAD-derived fecal microbiota transplanted (5xFAD-FMT) naïve mice were used to investigate the changes of M cells in the AD environment. Next, to establish the effect of M cell depletion on AD environments, 5xFAD mice and Spib knockout mice were bred, and behavioral and histological analyses were performed when M cell-depleted 5xFAD mice were six or nine months of age. RESULTS: In this study, we found that M cell numbers were increased in the colons of 5xFAD and 5xFAD-FMT mice compared to those of wild-type (WT) and WT-FMT mice. Moreover, the level of total bacteria infiltrating the colons increased in the AD-mimicked mice. The levels of M cell-related genes and that of infiltrating bacteria showed a significant correlation. The genetic inhibition of M cells (Spib knockout) in 5xFAD mice changed the composition of the gut microbiota, along with decreasing proinflammatory cytokine levels in the colons. M cell depletion ameliorated AD symptoms including amyloid-β accumulation, microglial dysfunction, neuroinflammation, and memory impairment. Similarly, 5xFAD-FMT did not induce AD-like pathologies, such as memory impairment and excessive neuroinflammation in Spib(−/−) mice. CONCLUSION: Therefore, our findings provide evidence that the inhibiting M cells can prevent AD progression, with therapeutic implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02966-9. BioMed Central 2023-11-27 /pmc/articles/PMC10680211/ /pubmed/38012646 http://dx.doi.org/10.1186/s12974-023-02966-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kim, Namkwon
Ju, In Gyoung
Jeon, Seung Ho
Lee, Yeongae
Jung, Min-Ji
Gee, Min Sung
Cho, Jae Seok
Inn, Kyung-Soo
Garrett-Sinha, Lee Ann
Oh, Myung Sook
Lee, Jong Kil
Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title_full Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title_fullStr Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title_full_unstemmed Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title_short Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
title_sort inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in alzheimer’s disease mouse model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680211/
https://www.ncbi.nlm.nih.gov/pubmed/38012646
http://dx.doi.org/10.1186/s12974-023-02966-9
work_keys_str_mv AT kimnamkwon inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT juingyoung inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT jeonseungho inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT leeyeongae inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT jungminji inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT geeminsung inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT chojaeseok inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT innkyungsoo inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT garrettsinhaleeann inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT ohmyungsook inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel
AT leejongkil inhibitionofmicrofoldcellsamelioratesearlypathologicalphenotypesbymodulatingmicroglialfunctionsinalzheimersdiseasemousemodel